Amarantus Bioscience Holdings, Inc. Overview
Amarantus Bioscience Holdings, Inc. filed as a Domestic Corporation in the State of Nevada on Friday, March 22, 2013 and is approximately eleven years old, as recorded in documents filed with Nevada Secretary of State.
Sponsored
Learn More
D&B Reports Available for
Amarantus Bioscience Holdings, Inc.
Network Visualizer
Advertisements
Key People
Who own Amarantus Bioscience Holdings, Inc.
Name | |
---|---|
Gerald Commissiong 2 |
NonDir
NonPres
NonSec
NonTreas
President
Secretary
Director
|
Marc Faerber 1 |
Treasurer
Secretary
|
Robert Farrell |
Treasurer
|
John Commissiong 1 |
Director
|
Robert C. Harris 1 |
Director
|
David Lowe |
Director
|
Joseph Rubinfeld |
Director
|
Donald Huffman |
Director
|
Iain Ross |
Director
|
Showing 8 records out of 9
Known Addresses for Amarantus Bioscience Holdings, Inc.
Corporate Filings for Amarantus Bioscience Holdings, Inc.
Nevada Secretary of State
Filing Type: | Domestic Corporation |
---|---|
Status: | Active |
State: | Nevada |
State ID: | E0146522013-6 |
Date Filed: | Friday, March 22, 2013 |
Registered Agent | National Registered Agents, Inc. of Nv |
California Secretary of State
Filing Type: | Statement & Designation By Foreign Corporation |
---|---|
Status: | Inactive |
State: | California |
Foreign State: | Nevada |
State ID: | 03607946 |
Date Filed: | Monday, September 30, 2013 |
Corporate Notes
Source | Date | Type | Note |
---|---|---|---|
3/22/2013 | Articles of Incorporation | Initial Stock Value: Par Value Shares: 1,010,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 1,010,000.00 | |
3/22/2013 | Merge In | ||
4/1/2013 | Designation | ||
4/2/2013 | Designation | ||
4/5/2013 | Amendment | ||
4/30/2013 | Initial List | ||
6/11/2013 | Designation | SERIES A PREFERRED | |
8/19/2013 | Designation | SERIES D 8% CONVERTIBLE PREFERRED STOCK | |
12/17/2013 | Registered Agent Change | ||
12/23/2013 | Admin Status Change | ||
12/24/2013 | Stock Split | 3,000,000 PREFERRED STOCK AT .001 PAR VALUE | |
6/19/2014 | Annual List | ||
6/30/2014 | Amended Designation | SERIES D CONVERTIBLE PREFERRED STOCK | |
10/9/2014 | Amendment | Previous Stock Value: Par Value Shares: 1,000,000,000 Value: $ 0.001 Par Value Shares: 3,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 1,003,000.00New Stock Value: Par Value Shares: 2,000,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 2,010,000.00 | |
11/7/2014 | Designation | SERIES E 12% CONVERTIBLE PREFERRED | |
12/19/2014 | Amended Designation | SERIES D CONVERTIBLE PREFERRED | |
12/19/2014 | Amended Designation | SERIES E CONVERTIBLE PREFERRED | |
1/13/2015 | Amended Designation | SERIES E CONVERTIBLE PREFERRED | |
3/2/2015 | Amended Designation | SERIES E CONVERTIBLE PREFERRED STOCK | |
4/2/2015 | Amended Designation | SERIES E 12% CONVERTIBLE PREFERRED STOCK | |
4/23/2015 | Annual List | ||
4/23/2015 | Designation | SERIES G PREFERRED STOCK | |
5/21/2015 | Stock Split | Previous Stock Value: Par Value Shares: 2,000,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 2,010,000.00New Stock Value: Par Value Shares: 13,333,334 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 23,333.33 | |
7/9/2015 | Amended Designation | SERIES E PREFERRED STOCK | |
7/10/2015 | Designation | SERIES G PREFERRED STOCK | |
9/3/2015 | Amendment | Previous Stock Value: Par Value Shares: 13,333,334 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 23,333.33New Stock Value: Par Value Shares: 35,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 45,000.00 | |
9/30/2015 | Designation | SERIES H CONVERTIBLE PREFERRED STOCK | |
11/5/2015 | Commercial Registered Agent Resignation | ||
12/9/2015 | Amendment | Previous Stock Value: Par Value Shares: 35,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 45,000.00New Stock Value: Par Value Shares: 150,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 160,000.00 | |
2/22/2016 | Amended Designation | SERIES E PREFERRED STOCK | |
2/24/2016 | Amendment | ||
3/1/2016 | Amended Designation | SERIES E PREFERRED STOCK | |
3/15/2016 | Annual List | ||
4/19/2016 | Amended Designation | SERIES E CONVERTIBLE PREFERRED STOCK | |
4/20/2016 | Amended Designation | SERIES H | |
3/9/2017 | Designation | SERIES F PREFERRED STOCK | |
3/27/2017 | Amendment | ||
11/13/2017 | Annual List | ||
2/22/2018 | Designation | SERIES I 12% CONVERTIBLE PREFERRED STOCK | |
2/23/2018 | Amendment | Previous Stock Value: Par Value Shares: 150,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 160,000.00New Stock Value: Par Value Shares: 250,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 260,000.00 | |
3/7/2018 | Amended Designation | SERIES B CONVERTIBLE PREFERRED STOCK | |
5/10/2018 | Annual List | ||
1/7/2019 | Amendment | Previous Stock Value: Par Value Shares: 10,000,000 Value: $ 0.001 Par Value Shares: 250,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 260,000.00New Stock Value: Par Value Shares: 400,000,000 Value: $ 0.001 Par Value Shares: 10,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 410,000.00 | |
4/29/2019 | Annual List | ||
4/30/2019 | Amended Designation | SERIES E CONVERTIBLE PREFERRED STOCK |
Trademarks for Amarantus Bioscience Holdings, Inc.
Serial Number:
86908798
Drawing Code: 4000
|
Advertisements
Sources
Nevada Secretary of State
Data last refreshed on Wednesday, May 8, 2019
Data last refreshed on Wednesday, May 8, 2019
California Secretary of State
Data last refreshed on Monday, April 4, 2022
Data last refreshed on Monday, April 4, 2022
What next?
Follow
Receive an email notification when changes occur for Amarantus Bioscience Holdings, Inc..
Notifications include:
- New company roles
- Change in active status
- Location updates
- New connections
Follow
Create Account
Create a free account to access additional details for Amarantus Bioscience Holdings, Inc. and other profiles that you visit
Benefits include:
- Access to more records
- Full screen network visualizer
- Follow profiles
- See how people are connected
Advertisements
6
Known Addresses
110 Wall St New York, NY 10005
45 Wall St New York, NY 10005
655 Montgomery St San Francisco, CA 94111
675 Almanor Ave Sunnyvale, CA 94085
953 Indiana St San Francisco, CA 94107
1018 Klamath River Ave Henderson, NV 89002
These addresses are known to be associated with Amarantus Bioscience Holdings, Inc. however they may be inactive or mailing addresses only. Please verify address for mailing or other purposes.
Wiki
2
Corporate Records